M06.26 Rheumatoid bursitis, knee

Name of the Condition

• Rheumatoid bursitis, knee

Summary

Rheumatoid bursitis of the knee is inflammation of the bursae (fluid-filled sacs that cushion joints) in the knee region, driven by rheumatoid arthritis (RA). This condition results from the immune system’s chronic inflammatory processes affecting the knee’s protective structures, leading to pain, swelling, and restricted mobility. Diagnosis requires correlation of clinical findings with RA history or serologic evidence.

Causes

Rheumatoid bursitis in the knee arises from the systemic inflammation of rheumatoid arthritis. The immune system’s attack on joint tissues extends to the knee’s bursae, causing fluid accumulation and irritation. While RA is the primary driver, mechanical stress or trauma to the knee may exacerbate inflammation in susceptible individuals.

Risk Factors

• Preexisting rheumatoid arthritis, increasing bursal inflammation risk.
• Advanced age, as RA severity often progresses over time.
• Prolonged knee overuse or pressure, which may irritate bursae.
• Systemic inflammation, as seen in active RA flares.

Symptoms

• Localized swelling and tenderness over the knee bursae.
• Pain with knee movement or pressure on the inflamed area.
• Reduced range of motion in the knee joint.
• Warmth or redness (if inflammation is acute).

Diagnosis

Diagnosis of rheumatoid bursitis, knee, involves clinical evaluation of symptoms, physical examination of the knee, and correlation with a history of rheumatoid arthritis. Imaging studies (e.g., ultrasound or MRI) may confirm bursal inflammation, while laboratory tests (e.g., rheumatoid factor or anti-CCP antibodies) support the underlying RA diagnosis. Aspiration of bursal fluid may be performed to rule out infection or crystal-induced arthritis.

Treatment Options

Treatment focuses on reducing inflammation and managing symptoms. Nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroid injections may alleviate pain and swelling. Disease-modifying antirheumatic drugs (DMARDs) target the underlying RA to prevent progression. Physical therapy helps maintain joint function, and activity modification reduces mechanical stress on the knee.

Prognosis and Follow-Up

Prognosis depends on the severity of RA and response to treatment. With appropriate management, symptoms often improve, but chronic inflammation may lead to persistent discomfort or functional limitations. Regular follow-up with a rheumatologist or orthopedic specialist is recommended to monitor RA activity and adjust therapy as needed.

Complications

Untreated or poorly controlled inflammation may result in chronic pain, reduced mobility, or bursal thickening. Rarely, infection or rupture of the bursa can occur. Long-term RA progression may also affect surrounding joint structures, leading to additional complications.

Lifestyle & Prevention

Maintaining a healthy weight reduces knee stress. Low-impact exercises (e.g., swimming) preserve mobility without exacerbating inflammation. Proper footwear and ergonomic adjustments minimize repetitive strain. RA management, including medication adherence and regular monitoring, helps prevent bursal flare-ups.

When to Seek Professional Help

Seek care if knee pain or swelling persists despite home care, worsens suddenly, or is accompanied by fever (suggesting infection). Prompt evaluation is necessary if mobility is significantly impaired or if RA symptoms (e.g., joint stiffness, fatigue) flare.

Tips for Medical Coders

Code M06.26 is specific to rheumatoid bursitis localized to the knee. Documentation should specify the anatomical site (knee) and confirm the underlying rheumatoid arthritis diagnosis. Ensure clinical correlation with RA history or serologic evidence to support the code assignment. Avoid using this code for non-rheumatoid bursal inflammation or unspecified sites.